Regulation of ENT1 expression and ENT1-dependent nucleoside transport by c-Jun N-terminal kinase

Biochemical and Biophysical Research Communications

Volumn 404, Issue 1, 2011, Pages 370-375

  Leisewitz, Andrea V ^a   Zimmerman, Eric I ^a   Huang, Min ^b   Jones, Shannon Z ^a   Yang, Jing ^a   Graves, Lee M ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Chemical stress; Chemotherapeutic drugs; Equilibrative nucleoside transporter; JNK

Indexed keywords

ALANINE; EQUILIBRATIVE NUCLEOSIDE TRANSPORTER 1; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE P38; SERINE; STRESS ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR AP 1;

ANIMAL CELL; ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; MODULATION; MOUSE; MUTANT; MYELOID LEUKEMIA; NONHUMAN; NUCLEOSIDE TRANSPORT; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION;

ANIMALS; ANTINEOPLASTIC AGENTS; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; BINDING SITES; CELL LINE, TUMOR; DOWN-REGULATION; DRUG RESISTANCE, NEOPLASM; EQUILIBRATIVE NUCLEOSIDE TRANSPORTER 1; GENE EXPRESSION REGULATION; HUMANS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MICE; NUCLEOSIDES; PROMOTER REGIONS, GENETIC;

EID: 78650856877     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2010.11.125     Document Type: Article

References (35)

1. Baldwin S.A., Beal P.R., Yao S.Y., King A.E., Cass C.E., Young J.D. The equilibrative nucleoside transporter family SLC29. Pflugers Arch. 2004, 447:735-743.
2. Giovannetti E., Mey V., Nannizzi S., Pasqualetti G., Del Tacca M., Danesi R. Pharmacogenetics of anticancer drug sensitivity in pancreatic cancer. Mol. Cancer Ther. 2006, 5:1387-1395.
3. Takagaki K., Katsuma S., Kaminishi Y., Horio T., Nakagawa S., Tanaka T., Ohgi T., Yano J. Gene-expression profiling reveals down-regulation of equilibrative nucleoside transporter 1 (ENT1) in Ara-C resistant CCRF-CEM-derived cells. J. Biochem. 2004, 136:733-740.
4. Pastor-Anglada M., Molina-Arcas M., Casado F.J., Bellosillo B., Colomer D., Gil J. Nucleoside transporters in chronic lymphocytic leukaemia. Leukemia 2004, 18:385-393.
5. Cai J., Damaraju V.L., Groulx N., Mowles D., Peng Y., Robins M.J., Cass C.E., Gros P. Two distinct molecular mechanisms underlying cytarabine resistance in human leukemic cells. Cancer Res. 2008, 68:2349-2357.
6. Mackey J.R., Mani R.S., Selner M., Mowles D., Young J.D., Belt J.A., Crawford C.R., Cass C.E. Functional nucleoside transporters are required for gemcitabine influx and manifestation of toxicity in cancer cell lines. Cancer Res. 1998, 58:4349-4357.
7. Seve P., Dumontet C. Chemoresistance in non-small cell lung cancer. Curr. Med. Chem. Anticancer Agents 2005, 5:73-88.
8. Cano-Soldado P., Molina-Arcas M., Alguero B., Larrayoz I., Lostao M.P., Grandas A., Casado F.J., Pastor-Anglada M. Compensatory effects of the human nucleoside transporters on the response to nucleoside-derived drugs in breast cancer MCF7 cells. Biochem. Pharmacol. 2008, 75:639-648.
9. Spratlin J., Sangha R., Glubrecht D., Dabbagh L., Young J.D., Dumontet C., Cass C., Lai R., Mackey J.R. The absence of human equilibrative nucleoside transporter 1 is associated with reduced survival in patients with gemcitabine-treated pancreas adenocarcinoma. Clin. Cancer Res. 2004, 10:6956-6961.
10. Farrell J.J., Elsaleh H., Garcia M., Lai R., Ammar A., Regine W.F., Abrams R., Benson A.B., Macdonald J., Cass C.E., Dicker A.P., Mackey J.R. Human equilibrative nucleoside transporter 1 levels predict response to gemcitabine in patients with pancreatic cancer. Gastroenterology 2009, 136:187-195.
11. Eltzschig H.K., Abdulla P., Hoffman E., Hamilton K.E., Daniels D., Schonfeld C., Loffler M., Reyes G., Duszenko M., Karhausen J., Robinson A., Westerman K.A., Coe I.R., Colgan S.P. HIF-1-dependent repression of equilibrative nucleoside transporter (ENT) in hypoxia. J. Exp. Med. 2005, 202:1493-1505.
12. Mackey J.R., Jennings L.L., Clarke M.L., Santos C.L., Dabbagh L., Vsianska M., Koski S.L., Coupland R.W., Baldwin S.A., Young J.D., Cass C.E. Immunohistochemical variation of human equilibrative nucleoside transporter 1 protein in primary breast cancers. Clin. Cancer Res. 2002, 8:110-116.
13. Petrovic V., Teng S., Piquette-Miller M. Regulation of drug transporters: during infection and inflammation. Mol. Interv. 2007, 7:99-111.
14. Soler C., Felipe A., Casado F.J., Celada A., Pastor-Anglada M. Nitric oxide regulates nucleoside transport in activated B lymphocytes. J. Leukoc. Biol. 2000, 67:345-349.
15. Verheij M., Bose R., Lin X.H., Yao B., Jarvis W.D., Grant S., Birrer M.J., Szabo E., Zon L.I., Kyriakis J.M., Haimovitz-Friedman A., Fuks Z., Kolesnick R.N. Requirement for ceramide-initiated SAPK/JNK signalling in stress-induced apoptosis. Nature 1996, 380:75-79.
16. MacKeigan J.P., Collins T.S., Ting J.P. MEK inhibition enhances paclitaxel-induced tumor apoptosis. J. Biol. Chem. 2000, 275:38953-38956.
17. Levresse V., Marek L., Blumberg D., Heasley L.E. Regulation of platinum-compound cytotoxicity by the c-Jun N-terminal kinase and c-Jun signaling pathway in small-cell lung cancer cells. Mol. Pharmacol. 2002, 62:689-697.
18. Han S.Y., Kim S.H., Heasley L.E. Differential gene regulation by specific gain-of-function JNK1 proteins expressed in Swiss 3T3 fibroblasts. J. Biol. Chem. 2002, 277:47167-47174.
19. Nishina H., Nakagawa K., Azuma N., Katada T. Activation mechanism and physiological roles of stress-activated protein kinase/c-Jun NH2-terminal kinase in mammalian cells. J. Biol. Regul. Homeost. Agents 2003, 17:295-302.
20. Cortez D., Stoica G., Pierce J.H., Pendergast A.M. The BCR-ABL tyrosine kinase inhibits apoptosis by activating a Ras-dependent signaling pathway. Oncogene 1996, 13:2589-2594.
21. Leisewitz A.V., Zimmerman E.I., Jones S.Z., Yang J., Graves L.M. Imatinib-resistant CML cells have low ENT activity but maintain sensitivity to gemcitabine. Nucleosides Nucleotides Nucl. Acids 2008, 27:779-786.
22. Huang M., Wang Y., Cogut S.B., Mitchell B.S., Graves L.M. Inhibition of nucleoside transport by protein kinase inhibitors. J. Pharmacol. Exp. Ther. 2003, 304:753-760.
23. Bone D.B., Hammond J.R. Nucleoside and nucleobase transporters of primary human cardiac microvascular endothelial cells: characterization of a novel nucleobase transporter. Am. J. Physiol. Heart Circ. Physiol. 2007.
24. Fuenzalida K.M., Aguilera M.C., Piderit D.G., Ramos P.C., Contador D., Quinones V., Rigotti A., Bronfman F.C., Bronfman M. Peroxisome proliferator-activated receptor gamma is a novel target of the nerve growth factor signaling pathway in PC12 cells. J. Biol. Chem. 2005, 280:9604-9609.
25. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001, 25:402-408.
26. Barbacid M., Vazquez D. (3H)anisomycin binding to eukaryotic ribosomes. J. Mol. Biol. 1974, 84:603-623.
27. Bone D.B., Robillard K.R., Stolk M., Hammond J.R. Differential regulation of mouse equilibrative nucleoside transporter 1 (mENT1) splice variants by protein kinase CK2. Mol. Membr. Biol. 2007, 24:294-303.
28. Davis R.J. Signal transduction by the JNK group of MAP kinases. Cell 2000, 103:239-252.
29. Stadheim T.A., Saluta G.R., Kucera G.L. Role of c-Jun N-terminal kinase/p38 stress signaling in 1-beta-d-arabinofuranosylcytosine-induced apoptosis. Biochem. Pharmacol. 2000, 59:407-418.
30. Teraishi F., Zhang L., Guo W., Dong F., Davis J.J., Lin A., Fang B. Activation of c-Jun NH2-terminal kinase is required for gemcitabine's cytotoxic effect in human lung cancer H1299 cells. FEBS Lett. 2005, 579:6681-6687.
31. Choi D.S., Handa M., Young H., Gordon A.S., Diamond I., Messing R.O. Genomic organization expression of the mouse equilibrative nitrobenzylthioinosine-sensitive nucleoside transporter 1 (ENT1) gene. Biochem. Biophys. Res. Commun. 2000, 277:200-208.
32. Johnson G.L., Nakamura K. The c-jun kinase/stress-activated pathway: regulation function and role in human disease. Biochim. Biophys. Acta 2007, 1773:1341-1348.
33. Dunn C., Wiltshire C., MacLaren A., Gillespie D.A. Molecular mechanism and biological functions of c-Jun N-terminal kinase signalling via the c-Jun transcription factor. Cell Signal. 2002, 14:585-593.
34. Chung H.T., Pae H.O., Choi B.M., Billiar T.R., Kim Y.M. Nitric oxide as a bioregulator of apoptosis. Biochem. Biophys. Res. Commun. 2001, 282:1075-1079.
35. Farias M., San Martin R., Puebla C., Pearson J.D., Casado J.F., Pastor-Anglada M., Casanello P., Sobrevia L. Nitric oxide reduces adenosine transporter ENT1 gene (SLC29A1) promoter activity in human fetal endothelium from gestational diabetes. J. Cell Physiol. 2006, 208:451-460.